This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Sky Labs' CART BP pro Expands
Business medical device launch

Sky Labs' CART BP pro Expands

Analysis based on 6 articles · First reported Jun 11, 2026 · Last updated Jun 11, 2026

Sentiment
70
Attention
4
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market for medical devices, particularly in hypertension management, is expected to see significant growth and innovation due to the advancements by Sky Labs>>>. The expansion of 'CART BP pro' into European markets, following its success and reimbursement in South Korea>>>, indicates a positive outlook for Sky Labs>>> and potentially other companies developing similar cuffless technologies.

Medical Devices Healthcare Biotechnology
Event Summary

Sky Labs>>>, a healthcare company, hosted symposiums at the European Society of Hypertension and British Cardiovascular Society conferences on June 11, 2026, to discuss its 'CART BP pro' device. This follows the Korean Society of Hypertension>>>'s updated guidelines recommending validated cuffless devices for blood pressure monitoring. South Korea>>> is emerging as a leader in the clinical application of these devices, with 'CART BP pro' having over 260,000 cumulative prescriptions as of May 2026, backed by its 2024 national health insurance reimbursement approval. Global experts, including Professor George Stergiou and Professor Carmel McEniery, praised South Korea>>>'s proactive approach. Sky Labs>>> has also obtained European medical device certification CE-MDR and completed registration with the UK's United Kingdom — Medicines and Healthcare products Regulatory Agency>>>, planning full-scale expansion into European markets. The company also launched 'CART BP', a consumer-grade device, in September 2025.

Entities Involved
oth
Sky Labs
Sky Labs is the developer and operator of the 'CART BP pro' device, which is gaining global recognition and expanding into European markets. This event significantly boosts its market position and potential for growth.
Importance 100.0 Sentiment 80.0
cnt
South Korea
South Korea is highlighted as a leader in the clinical application of cuffless blood pressure monitors, providing a favorable environment for devices like Sky Labs>>>' 'CART BP pro' to thrive due to its health insurance reimbursement system.
Importance 70.0 Sentiment 60.0
per
Jack Byung-hwan Lee
Jack Byung-hwan Lee is the CEO of Sky Labs>>> and is leading the company's efforts in global expansion and innovation in cuffless blood pressure monitoring.
Importance 60.0 Sentiment 70.0
ngo
Korean Society of Hypertension
The Korean Society of Hypertension updated its guidelines to recommend validated cuffless devices, which directly benefits Sky Labs>>>' 'CART BP pro' and positions South Korea as a leader in this field.
Importance 50.0 Sentiment 0.0
ngo
European Society of Hypertension
The European Society of Hypertension hosted a symposium where Sky Labs>>> presented its 'CART BP pro' device, contributing to its academic validation and market acceptance.
Importance 40.0 Sentiment 0.0
ngo
British Cardiovascular Society
The British Cardiovascular Society hosted a symposium where Sky Labs>>> presented its 'CART BP pro' device, contributing to its academic validation and market acceptance.
Importance 40.0 Sentiment 0.0
govactor
South Korea — Health Insurance Review and Assessment Service
The South Korea — Health Insurance Review and Assessment Service (HIRA) recognized 'CART BP pro' for reimbursement, facilitating its adoption in South Korean medical institutions.
Importance 40.0 Sentiment 0.0
govactor
United Kingdom — Medicines and Healthcare products Regulatory Agency
The United Kingdom — Medicines and Healthcare products Regulatory Agency (MHRA) registered 'CART BP pro', enabling Sky Labs>>>' expansion into the UK market.
Importance 40.0 Sentiment 0.0
per
George Stergiou
George Stergiou, President of the International Society of Hypertension, expressed encouragement for South Korea's exploration of cuffless blood pressure monitors and the potential of 'CART BP pro'.
Importance 30.0 Sentiment 0.0
per
Carmel McEniery
Carmel McEniery from the University of Cambridge praised South Korea's medical system and clinical environment for its leadership in cuffless blood pressure monitor application.
Importance 30.0 Sentiment 0.0
per
Philip Lewis
Philip Lewis evaluated the 'CART BP pro' device positively, noting its potential in hypertension management and other clinical fields.
Importance 30.0 Sentiment 0.0
per
Geu-ru Hong
Geu-ru Hong from Severance Cardiovascular Hospital provided positive feedback on the patient convenience of ring-type cuffless blood pressure monitoring, calling it a 'game changer'.
Importance 30.0 Sentiment 0.0
per
Kwang-il Kim
Kwang-il Kim, President of the Korean Society of Hypertension, highlighted South Korea's advantageous environment for innovative medical devices and the positive patient acceptance of ring-type monitors.
Importance 30.0 Sentiment 0.0
cnt
United Kingdom
The United Kingdom is a target market for Sky Labs>>>' expansion after receiving regulatory approval from the United Kingdom — Medicines and Healthcare products Regulatory Agency>>>.
Importance 30.0 Sentiment 0.0
ngo
International Society of Hypertension
The President of the International Society of Hypertension commented positively on the advancements in cuffless blood pressure monitoring, indirectly supporting the market for devices like 'CART BP pro'.
Importance 20.0 Sentiment 0.0
+ 1 more entities View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.